AB Science: The clinical development of masitinib in sickle cell disease is among the 19 winning projects under the sixth call for Hospital-Inuversity Research in health (RHU) -November 27, 2023 at 02:05 am EST

PRESS RELEASE THE CLINICAL DEVELOPMENT OF MASITINIB IN SICKLE CELL DISEASE, A HIGHLY PREVALENT GENETIC CONDITION, IS AMONG THE 19 WINNING PROJECTS UNDER THE SIXTH CALL FOR HOSPITAL-UNIVERSITY...

Related Keywords

United States ,Paris ,France General ,France ,Alain Moussy ,Olivier Hermine ,National Research Agency ,University Research In Health Recherche Hospitalo Universitaire ,University Research In Health ,Investments Program ,University Research ,Recherche Hospitalo Universitaire ,Future Investments ,Future Investments Program ,Assistance Publique H ,Euronext Paris ,Markets ,